NCT05027789 (BB2) is a NA clinical trial of Self-Guided in Memory Disorders, sponsored by University of California, Davis.

Who is sponsoring NCT05027789?

NCT05027789 is sponsored by University of California, Davis.

What drugs are being tested in NCT05027789?

Interventions in NCT05027789: Self-Guided, Structured Group.

What condition does NCT05027789 study?

NCT05027789 studies Memory Disorders, Cognitive Impairment.

Is NCT05027789 still recruiting?

NCT05027789 is currently active, enrolled. Last updated 8 October 2025.

Last reviewed 2025-10-08 · How we verify

NCT05027789: BB2

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Brain Boosters 2 in Persons at Risk for Alzheimer's Disease: a Digital Application Supported Intervention

Active, enrolled NA Last updated 8 October 2025

What this trial tests

NA trial testing Self-Guided in Memory Disorders in 263 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline

13 August 2021

Primary endpoint
31 August 2026

31 August 2026

Quick facts

Lead sponsor	University of California, Davis
Phase	NA
Status	Active, enrolled
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	prevention
Enrollment	263
Start date	13 August 2021
Primary completion	31 August 2026
Estimated completion	31 August 2026
Sites	1 location across United States

Drugs / interventions tested

Self-Guided
Structured Group

Conditions studied

Memory Disorders — all drugs for Memory Disorders →
Cognitive Impairment — all drugs for Cognitive Impairment →

Sponsor

University of California, Davis

Who can join

Adults 65 to 90, any sex, with Memory Disorders or Cognitive Impairment. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this research is to determine if training in memory support aids and healthy lifestyle activities (physical exercise, mentally stimulating activities and stress management) can have a positive effect on memory, thinking, and activities that people do every day. Participation in this study will involve being placed into one of two groups: a Self-Guided Intervention Group or a Structured Intervention Group. Both groups will be asked to attend group sessions in which they will be provided education on memory support strategies and lifestyle changes. The Structured Intervention Group will also be provided with an iPad and a digital application (called EMMA) to track their activity. Study participation involves a 6-month intervention and completing outcome measures at 4 different time points for up to a year.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Self-Guided

Trials testing the same drug.

NCT06848491 — Using Tailored mHealth Strategies to Promote Weight Management Among Adolescent and Young Adult Cancer Survivors · NA · recruiting
NCT05555264 — Enhancing Internet-delivered Cognitive Behaviour Therapy for Alcohol Misuse · NA · active not recruiting

Other recruiting trials for Memory Disorders

Currently open trials in the same condition.

NCT06260228 — HOme-Based Self-management and COgnitive Training CHanges Lives (HOBSCOTCH)-Parkinson's Disease (HOBSCOTCH-Parkinson's) · NA · active not recruiting
NCT06145737 — HOme-Based Self-management and COgnitive Training CHanges Lives (HOBSCOTCH) - Multiple Sclerosis (MS) · NA · active not recruiting
NCT06427265 — Machine Learning-based Longitudinal Study of Post-ICU Syndrome Development Trajectory in Critically Ill Patients and Con · recruiting
NCT06124339 — Brain Health Virtual Reality Study · NA · recruiting
NCT05709210 — Pilot Study on the Feasibility of Using Smartphone Data as a Diagnostic Marker for Alzheimer's Disease · NA · recruiting

Other University of California, Davis trials

Trials by the same sponsor.

NCT07024498 — Coordinating Outpatient bupreNorphiNe for Emergency Care and Continuing Treatment · NA · not yet recruiting
NCT07322133 — Dopamine vs. Norepinephrine for Hypotension in Neonates With Pulmonary Hypertension (DONE) · Phase 4 · recruiting
NCT07384767 — Efficacy and Safety of Topical Timolol in Secondary Intention Surgical Wounds Healing · Phase 2 · not yet recruiting
NCT07267494 — Image-Guided Herniorrhaphy Study · NA · not yet recruiting
NCT04614714 — Milk Volume Outcomes Following Oral Nicotinamide Riboside Supplementation in Mothers of Extremely Preterm Infants · Phase 2, PHASE3 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05027789 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of California, Davis
Last refreshed: 8 October 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05027789.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing